Drug patents in Japan
Senate Commerce/Foreign Commerce Subcommittee, chaired by Sen. Rockefeller (DW. Va), is planning a hearing Feb. 28 on U.S. companies getting and enforcing patents in Japan. SmithKline's Alan Lourie is scheduled to testify, along with Michael Kirk, assistant commissioner for external affairs in the Commerce Department's Patent & Trademark Office, and A. E. Hirsch, representing the Pacific Industrial Property Association. Hearing will be held at 9:30 a.m. in SR-253, Russell Senate Office building.
You may also be interested in...
Novavax aims to recruit 10,000 subjects in the UK, and will include a flu vaccination co-administration for some participants.
Alvogen sister company Alvotech, is continuing to extend its network of commercial partners by expanding its partnership with DKSH, a Swiss market expansion services group, for the commercialization of six biosimilars in Asian markets.
The UK regulator wants to be a “catalyst for change” in reducing regulatory burdens, saying that better regulation based on science is in everyone’s interest.